0002116676-26-000001.txt : 20260311 0002116676-26-000001.hdr.sgml : 20260311 20260310173106 ACCESSION NUMBER: 0002116676-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260311 DATE AS OF CHANGE: 20260310 EFFECTIVENESS DATE: 20260311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Everest Biolabs, Inc. CENTRAL INDEX KEY: 0002116676 ORGANIZATION NAME: EIN: 991854764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-576080 FILM NUMBER: 26740655 BUSINESS ADDRESS: STREET 1: 204 SECOND AVE STREET 2: SUITE 102 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 6172140840 MAIL ADDRESS: STREET 1: 204 SECOND AVE STREET 2: SUITE 102 CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0708 D LIVE 0002116676 Everest Biolabs, Inc. 204 SECOND AVE SUITE 102 WALTHAM MA MASSACHUSETTS 02451 6172140840 DELAWARE None None Corporation true 2024 George Daaboul c/o Everest Biolabs, Inc. 204 Second Ave, Ste 102 Waltham MA MASSACHUSETTS 02451 Executive Officer Director David Freedman c/o Everest Biolabs, Inc. 204 Second Ave, Ste 102 Waltham MA MASSACHUSETTS 02451 Executive Officer Director David Walt c/o Everest Biolabs, Inc. 204 Second Ave, Ste 102 Waltham MA MASSACHUSETTS 02451 Director Paul Meister c/o Everest Biolabs, Inc. 204 Second Ave, Ste 102 Waltham MA MASSACHUSETTS 02451 Director Vinit Nijhawan c/o Everest Biolabs, Inc. 204 Second Ave, Ste 102 Waltham MA MASSACHUSETTS 02451 Director Biotechnology Decline to Disclose 06b false 2026-02-25 false true false 0 5650000 4350000 1300000 false 7 0 0 0 false Everest Biolabs, Inc. /s/ George Daaboul George Daaboul Chief Executive Officer 2026-03-06